Abstract
Vitiligo is a multifactorial autoimmune disease characterized by hypopigmented macules and patches on the skin and/or mucous membranes, which occur secondary to the destruction of melanocytes. Currently, therapeutic strategies still present unsatisfactory repigmentation rates and high indices of recurrence and side effects. Because of this, the search for new treatments has emerged for th…